SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-19-005055
Filing Date
2019-08-01
Accepted
2019-08-01 07:16:41
Documents
14
Period of Report
2019-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_080119.htm   iXBRL 8-K 21143
2 EXHIBIT 99.1 exh_991.htm EX-99.1 194255
  Complete submission text file 0001171843-19-005055.txt   444182

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3095
4 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25969
5 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 35566
6 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 24600
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_080119_htm.xml XML 3109
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 19990904
SIC: 2834 Pharmaceutical Preparations